Publications by authors named "Omid A Hamid"

Claim this Profile
A
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
Sandra P D'Angelo, Omid A Hamid, Ahmad Tarhini, Dirk Schadendorf, Bartosz Chmielowski

Invest New Drugsยท February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis